|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
75.200 +2.600 (+3.581%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 7,422,753 | 7,643,665 | 1,265,265 |
| Net Cash from / (used in) Investing Activities | -- | (1,911,986) | 1,222,314 | 390,291 |
| Net Cash from / (used in) Financing Activities | -- | (1,550,589) | (3,144,428) | (318,771) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 3,960,178 | 5,721,551 | 1,336,785 |
| Cash & Cash Equivalents at beginning of period | -- | 20,271,524 | 14,537,437 | 13,120,156 |
| Effect of Foreign Exchange Rate Changes | -- | 7,400 | 12,536 | 80,496 |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 24,239,102 | 20,271,524 | 14,537,437 |
| Remarks: | Real time quote last updated: 31/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,450,107 |
| %Change | 29.675% |
| EPS / (LPS) | RMB 0.700 |
| NBV Per Share (¥) | RMB 8.820 |